Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9415515.
- Also identified by DOI 10.1016/S0304-3959(97)00096-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case report describes the successful alleviation of the pain of pancreatic carcinoma with intravenous phentolamine mesylate. A 2 day infusion gave relief for 26 days on the first occasion and for 12 weeks after the second infusion. The possible mode of action is discussed.
Medical subject headings
- Analgesics, Non-Narcotic
- Pain
- Pancreatic Neoplasms
- Phentolamine